ACT-BT: Access to Clinical Trials for Brain Tumours
We’ve launched a new project called ACT-BT to help make it easier for people diagnosed with brain tumours to access promising new treatments through clinical trials.
For people diagnosed with a brain tumour
Learn more about ACT-BT and how to speak to your healthcare team about getting being referred.
For healthcare professionals to refer patients
Find out how to refer a patient to the ACT-BT panel and what information you’ll need to include.
What is ACT-BT?
Access to Clinical Trials for Brain Tumours (ACT-BT) is a new initiative funded and co-created by The Brain Tumour Charity. This project aims to make it easier for people diagnosed with brain tumours to access emerging treatments through clinical trials.
How does the process work?
Step one
If an adult who’s been diagnosed with a primary brain tumour agrees, their oncologist, a Clinical Nurse Specialist or a research nurse completes the short referral form and emails it to the ACT-BT team.
Step two
The panel meets weekly to discuss referrals and identify any clinical trials that may be suitable.
Step three
The person diagnosed with a brain tumour receives timely, personalised advice from their healthcare team about opportunities to participate in research.
We know the people diagnosed with brain tumours want access to emerging treatments. But too often the burden of searching for suitable clinical trials falls on people coming to terms with a new diagnosis or healthcare professionals working in already under-resourced environments.
Professor Susan Short, ACT-BT lead
Through ACT-BT, we hope remove some of the barriers preventing the brain tumour community from accessing promising new treatments through clinical trials by providing them timely, personalised advice about trials they may be eligible for.
Learn more about ACT-BT
Hear from the ACT-BT lead
Take a listen to our podcast interview with project lead, Professor Susan Short.
Speak to us for more information
Speak to our Support and Information team today by emailing [email protected], calling 0808 800 0004 or hitting “Chat with support” to start a live chat.